CHICAGO (CBS) – A groundbreaking treatment for type 1 diabetes is showing promising results for patients in Chicago. It's a ...

and sometimes people are told to change their diabetes treatment. If you or your family member start a new diabetes treatment, make sure to ask the right questions from the doctor. Let us tell you ...

For the first time, scientists in China reprogrammed a woman's fat cells to turn them into insulin-making pancreatic cells ...

"There is hope, including advances in early detection and treatment spearheaded by retina specialists that can help people ...

Independent advisers to the U.S. Food and Drug Administration on Thursday voted against recommending Lexicon Pharmaceuticals' ...

The insulin is facing supply shortages as diabetes patients increasingly turn to GLP-1 weight loss drugs such as Ozempic and ...

Dr. Piotr Witkowski, director of the pancreatic and islet transplant program at the University of Chicago Transplant ...

The Danish company’s share price rise of 7 per cent this year lags far behind its rival Eli Lilly’s 36 per cent, as the US company has gradually increased its share of the obesity and diabetes market ...

A new study out this week suggests that sticking to the diet could even help improve beta-cell function in people with type 2 ...

Marketed as Lantidra, it is a cellular therapy drug used to treat type 1 diabetes. Donislecel is an allogeneic (donor) pancreatic islet cell treatment derived from deceased donor pancreatic cells.

The active ingredient in Ozempic was associated with a 40% to 70% lower risk of a first-time Alzheimer’s diagnosis in ...

In 2025, children within the TEDDY study will submit their final samples at research clinics in Sweden, Finland, Germany and ...